Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stain View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1997-10

AUTHORS

H J Broxterman, G J Schuurhuis, J Lankelma, J W Oberink, C A Eekman, A M Claessen, K Hoekman, M Poot, H M Pinedo

ABSTRACT

Progress in our understanding of the contribution of P-glycoprotein (P-gp)-mediated resistance to chemotherapy failure in haematological as well as solid tumours has been hampered by the lack of highly sensitive, reliable methods for the detection of P-gp function in fresh human tumour cells. The present study identifies the novel nucleic acid stain SYTO16 as a highly sensitive and specific dye to assess P-gp function. The effect of P-gp is expressed here as the ratio of dye fluorescence (RF) from cells incubated with dye with or without 2 microM of the P-gp inhibitor PSC 833. Using flow cytometric analysis, an RF of 0.9 was found for SYTO16 in the KB3-1 (P-gp-) and 1.6 in KB8 (P-gp+) cells. Three types of patients' cells were studied: (1) in haematopoietic CD34+ cells, which are known to express P-gp, the RF was 6.0 for SYTO16 compared with 2.5 for rhodamine 123 and 1.3 for daunorubicin (mean of five individuals); (2) in acute myeloid leukaemia cells, the RF for SYTO16 was 1.0 in P-gp- and 4.5 in P-gp+ samples; (3) for the first time, we have quantitated P-gp function in fresh human solid tumour (sarcoma) cells. We found, in a P-gp+ leiomyosarcoma, an RF of 16 for SYTO16 and 2.7 for daunorubicin. This means that complete inhibition of P-gp function in these sarcoma cells would lead to an increase of daunorubicin accumulation with 170% compared with 30% in the CD34+ cells. Next, we showed that SYTO16 could be fixed in nuclei by 3.6% formaldehyde treatment, allowing quantification of the nuclear fluorescence on cytospins by laser scanning microscopy. In conclusion, SYTO16 proved to have a combination of favourable properties: it can be excited at 488 nm and has large fluorescence enhancement upon binding to nucleic acids, allowing the use of low, nontoxic (< 10 nM) concentrations. Because the RF for SYTO16 is much higher than for daunorubicin, it can be applied for the determination of P-gp function in relatively small numbers of low-P-gp-expressing tumour cells by laser scanning microscopy. Individual sarcomas were found to have high P-gp function compared with CD34+ cells. This assay may be used to select patients for P-gp modulation protocols. More... »

PAGES

1029

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.1997.503

DOI

http://dx.doi.org/10.1038/bjc.1997.503

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1022392490

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9376262


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ATP Binding Cassette Transporter, Subfamily B, Member 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, CD", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorescent Dyes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "KB Cells", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Myeloid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukosialin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Microscopy, Confocal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sarcoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sialoglycoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Staining and Labeling", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Broxterman", 
        "givenName": "H J", 
        "id": "sg:person.015516000634.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015516000634.07"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Schuurhuis", 
        "givenName": "G J", 
        "id": "sg:person.07406565254.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07406565254.15"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Lankelma", 
        "givenName": "J", 
        "id": "sg:person.0655351752.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655351752.04"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Oberink", 
        "givenName": "J W", 
        "id": "sg:person.01265440600.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265440600.54"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Eekman", 
        "givenName": "C A", 
        "id": "sg:person.0670102621.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670102621.58"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Claessen", 
        "givenName": "A M", 
        "id": "sg:person.01233604561.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233604561.15"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Hoekman", 
        "givenName": "K", 
        "id": "sg:person.0701655230.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701655230.21"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Poot", 
        "givenName": "M", 
        "type": "Person"
      }, 
      {
        "familyName": "Pinedo", 
        "givenName": "H M", 
        "id": "sg:person.013437631522.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013437631522.70"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/316820a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002793125", 
          "https://doi.org/10.1038/316820a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0005-2736(76)90160-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003305167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0005-2736(76)90160-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003305167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910420314", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004003162"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0959-8049(96)00045-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012023031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.371", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020465696", 
          "https://doi.org/10.1038/bjc.1995.371"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1995.371", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020465696", 
          "https://doi.org/10.1038/bjc.1995.371"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910610622", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025448202"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01806527", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032011172", 
          "https://doi.org/10.1007/bf01806527"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01806527", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032011172", 
          "https://doi.org/10.1007/bf01806527"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1432-1033.1992.tb17083.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038817760"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0092-8674(91)90141-k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042233556"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0014-4827(89)90318-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044150193"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.87.18.7160", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053382835"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079935271", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082406766", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082504424", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082563921", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082650615", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082651925", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082889421", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082903123", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1997-10", 
    "datePublishedReg": "1997-10-01", 
    "description": "Progress in our understanding of the contribution of P-glycoprotein (P-gp)-mediated resistance to chemotherapy failure in haematological as well as solid tumours has been hampered by the lack of highly sensitive, reliable methods for the detection of P-gp function in fresh human tumour cells. The present study identifies the novel nucleic acid stain SYTO16 as a highly sensitive and specific dye to assess P-gp function. The effect of P-gp is expressed here as the ratio of dye fluorescence (RF) from cells incubated with dye with or without 2 microM of the P-gp inhibitor PSC 833. Using flow cytometric analysis, an RF of 0.9 was found for SYTO16 in the KB3-1 (P-gp-) and 1.6 in KB8 (P-gp+) cells. Three types of patients' cells were studied: (1) in haematopoietic CD34+ cells, which are known to express P-gp, the RF was 6.0 for SYTO16 compared with 2.5 for rhodamine 123 and 1.3 for daunorubicin (mean of five individuals); (2) in acute myeloid leukaemia cells, the RF for SYTO16 was 1.0 in P-gp- and 4.5 in P-gp+ samples; (3) for the first time, we have quantitated P-gp function in fresh human solid tumour (sarcoma) cells. We found, in a P-gp+ leiomyosarcoma, an RF of 16 for SYTO16 and 2.7 for daunorubicin. This means that complete inhibition of P-gp function in these sarcoma cells would lead to an increase of daunorubicin accumulation with 170% compared with 30% in the CD34+ cells. Next, we showed that SYTO16 could be fixed in nuclei by 3.6% formaldehyde treatment, allowing quantification of the nuclear fluorescence on cytospins by laser scanning microscopy. In conclusion, SYTO16 proved to have a combination of favourable properties: it can be excited at 488 nm and has large fluorescence enhancement upon binding to nucleic acids, allowing the use of low, nontoxic (< 10 nM) concentrations. Because the RF for SYTO16 is much higher than for daunorubicin, it can be applied for the determination of P-gp function in relatively small numbers of low-P-gp-expressing tumour cells by laser scanning microscopy. Individual sarcomas were found to have high P-gp function compared with CD34+ cells. This assay may be used to select patients for P-gp modulation protocols.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.1997.503", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "76"
      }
    ], 
    "name": "Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stain", 
    "pagination": "1029", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6aae833692d0b35a6bc2d0e4305a3166f08c960547bad53895433770f08fffed"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9376262"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.1997.503"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1022392490"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.1997.503", 
      "https://app.dimensions.ai/details/publication/pub.1022392490"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:12", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000361_0000000361/records_53993_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc1997503"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1997.503'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1997.503'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1997.503'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1997.503'


 

This table displays all metadata directly associated to this object as RDF triples.

232 TRIPLES      21 PREDICATES      64 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.1997.503 schema:about N049cc7c45ca145909a9b9ad4efa0e10d
2 N09c509fe37984b0387e518eac44636aa
3 N26ad07e5bb2f441393662b7e0e80e083
4 N32f635994c484184a2aa2121517ea636
5 N3e7f651750c2407f9e4dd90c926b3b2b
6 N58da072611e745028d978cab608fc644
7 N5b5637fa90dc4aebae00be6dd2cb6728
8 N5ef0da99a138448ca20c1e6dd365a381
9 N67dde533570c48e09d886f55d5e89dba
10 Ncc2a3c2d4a4d42168b7d934db695ca86
11 Nd589a1b029084796817c89474318da92
12 Ndbff4f7846ce4ca88238b90aaa5b7e5e
13 Ndc54694580ce40b2b54a7c6d77bb8a49
14 Ndd52cf0f686e4ea6ac1f656ac0863ce5
15 Ne0b6827978764368a519100e2d2838eb
16 Ne8768a58c87f46d3954c140631fac623
17 anzsrc-for:11
18 anzsrc-for:1112
19 schema:author Nf1e30c18e508480c957428906dd8d388
20 schema:citation sg:pub.10.1007/bf01806527
21 sg:pub.10.1038/316820a0
22 sg:pub.10.1038/bjc.1995.371
23 https://app.dimensions.ai/details/publication/pub.1079935271
24 https://app.dimensions.ai/details/publication/pub.1082406766
25 https://app.dimensions.ai/details/publication/pub.1082504424
26 https://app.dimensions.ai/details/publication/pub.1082563921
27 https://app.dimensions.ai/details/publication/pub.1082650615
28 https://app.dimensions.ai/details/publication/pub.1082651925
29 https://app.dimensions.ai/details/publication/pub.1082889421
30 https://app.dimensions.ai/details/publication/pub.1082903123
31 https://doi.org/10.1002/ijc.2910420314
32 https://doi.org/10.1002/ijc.2910610622
33 https://doi.org/10.1016/0005-2736(76)90160-7
34 https://doi.org/10.1016/0014-4827(89)90318-2
35 https://doi.org/10.1016/0092-8674(91)90141-k
36 https://doi.org/10.1016/0959-8049(96)00045-7
37 https://doi.org/10.1073/pnas.87.18.7160
38 https://doi.org/10.1111/j.1432-1033.1992.tb17083.x
39 schema:datePublished 1997-10
40 schema:datePublishedReg 1997-10-01
41 schema:description Progress in our understanding of the contribution of P-glycoprotein (P-gp)-mediated resistance to chemotherapy failure in haematological as well as solid tumours has been hampered by the lack of highly sensitive, reliable methods for the detection of P-gp function in fresh human tumour cells. The present study identifies the novel nucleic acid stain SYTO16 as a highly sensitive and specific dye to assess P-gp function. The effect of P-gp is expressed here as the ratio of dye fluorescence (RF) from cells incubated with dye with or without 2 microM of the P-gp inhibitor PSC 833. Using flow cytometric analysis, an RF of 0.9 was found for SYTO16 in the KB3-1 (P-gp-) and 1.6 in KB8 (P-gp+) cells. Three types of patients' cells were studied: (1) in haematopoietic CD34+ cells, which are known to express P-gp, the RF was 6.0 for SYTO16 compared with 2.5 for rhodamine 123 and 1.3 for daunorubicin (mean of five individuals); (2) in acute myeloid leukaemia cells, the RF for SYTO16 was 1.0 in P-gp- and 4.5 in P-gp+ samples; (3) for the first time, we have quantitated P-gp function in fresh human solid tumour (sarcoma) cells. We found, in a P-gp+ leiomyosarcoma, an RF of 16 for SYTO16 and 2.7 for daunorubicin. This means that complete inhibition of P-gp function in these sarcoma cells would lead to an increase of daunorubicin accumulation with 170% compared with 30% in the CD34+ cells. Next, we showed that SYTO16 could be fixed in nuclei by 3.6% formaldehyde treatment, allowing quantification of the nuclear fluorescence on cytospins by laser scanning microscopy. In conclusion, SYTO16 proved to have a combination of favourable properties: it can be excited at 488 nm and has large fluorescence enhancement upon binding to nucleic acids, allowing the use of low, nontoxic (< 10 nM) concentrations. Because the RF for SYTO16 is much higher than for daunorubicin, it can be applied for the determination of P-gp function in relatively small numbers of low-P-gp-expressing tumour cells by laser scanning microscopy. Individual sarcomas were found to have high P-gp function compared with CD34+ cells. This assay may be used to select patients for P-gp modulation protocols.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree true
45 schema:isPartOf N111c4d6ea3974010b9f71171376719bc
46 N86e97707f0f243db90169db553fe80ae
47 sg:journal.1017082
48 schema:name Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stain
49 schema:pagination 1029
50 schema:productId N1622e47549e742bd89439c361deb1a19
51 Na0b7d6ca24b346fe85b12cd54333f1a5
52 Na60b9c29e6434575b1118ae5fad3da3f
53 Nf112bd6a4e7f4b13aa2c07c4a7d90a2a
54 Nf64a87553aa8440abaacd78e6f2ea6ee
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022392490
56 https://doi.org/10.1038/bjc.1997.503
57 schema:sdDatePublished 2019-04-11T12:12
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N5f28bf69d53d480eb327e7f02ed2adbb
60 schema:url https://www.nature.com/articles/bjc1997503
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N049cc7c45ca145909a9b9ad4efa0e10d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name ATP Binding Cassette Transporter, Subfamily B, Member 1
66 rdf:type schema:DefinedTerm
67 N09c509fe37984b0387e518eac44636aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Staining and Labeling
69 rdf:type schema:DefinedTerm
70 N111c4d6ea3974010b9f71171376719bc schema:issueNumber 8
71 rdf:type schema:PublicationIssue
72 N1622e47549e742bd89439c361deb1a19 schema:name readcube_id
73 schema:value 6aae833692d0b35a6bc2d0e4305a3166f08c960547bad53895433770f08fffed
74 rdf:type schema:PropertyValue
75 N26ad07e5bb2f441393662b7e0e80e083 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Sensitivity and Specificity
77 rdf:type schema:DefinedTerm
78 N26f326105aa144a2aa09a353491df3dd rdf:first sg:person.0655351752.04
79 rdf:rest Nbac4f882d1de41429809aaa2d609eb8d
80 N2a2f57d0c71648b19e8b4e245c3a8aa3 rdf:first sg:person.01233604561.15
81 rdf:rest N2f5830cefe20486b9e673ada05d019b6
82 N2f5830cefe20486b9e673ada05d019b6 rdf:first sg:person.0701655230.21
83 rdf:rest N3ac58be4d57147cdb116a31c10d86446
84 N32f635994c484184a2aa2121517ea636 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Leukosialin
86 rdf:type schema:DefinedTerm
87 N3ac58be4d57147cdb116a31c10d86446 rdf:first Ne58537c3f1734aed8e27e03d16f0b39a
88 rdf:rest Nf6497e5c82144997bf60e57b6603fda2
89 N3e7f651750c2407f9e4dd90c926b3b2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Microscopy, Confocal
91 rdf:type schema:DefinedTerm
92 N58da072611e745028d978cab608fc644 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Sialoglycoproteins
94 rdf:type schema:DefinedTerm
95 N5b5637fa90dc4aebae00be6dd2cb6728 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Sarcoma
97 rdf:type schema:DefinedTerm
98 N5ef0da99a138448ca20c1e6dd365a381 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Acute Disease
100 rdf:type schema:DefinedTerm
101 N5f28bf69d53d480eb327e7f02ed2adbb schema:name Springer Nature - SN SciGraph project
102 rdf:type schema:Organization
103 N67dde533570c48e09d886f55d5e89dba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Antigens, CD
105 rdf:type schema:DefinedTerm
106 N86e97707f0f243db90169db553fe80ae schema:volumeNumber 76
107 rdf:type schema:PublicationVolume
108 Na0b7d6ca24b346fe85b12cd54333f1a5 schema:name pubmed_id
109 schema:value 9376262
110 rdf:type schema:PropertyValue
111 Na60b9c29e6434575b1118ae5fad3da3f schema:name doi
112 schema:value 10.1038/bjc.1997.503
113 rdf:type schema:PropertyValue
114 Nbac4f882d1de41429809aaa2d609eb8d rdf:first sg:person.01265440600.54
115 rdf:rest Ncab90dc489a948288cad0336bd6589a3
116 Ncab90dc489a948288cad0336bd6589a3 rdf:first sg:person.0670102621.58
117 rdf:rest N2a2f57d0c71648b19e8b4e245c3a8aa3
118 Ncc2a3c2d4a4d42168b7d934db695ca86 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name DNA, Neoplasm
120 rdf:type schema:DefinedTerm
121 Nd589a1b029084796817c89474318da92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Flow Cytometry
123 rdf:type schema:DefinedTerm
124 Ndbff4f7846ce4ca88238b90aaa5b7e5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Humans
126 rdf:type schema:DefinedTerm
127 Ndc54694580ce40b2b54a7c6d77bb8a49 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name KB Cells
129 rdf:type schema:DefinedTerm
130 Ndd52cf0f686e4ea6ac1f656ac0863ce5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Fluorescent Dyes
132 rdf:type schema:DefinedTerm
133 Ne0b6827978764368a519100e2d2838eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name RNA, Neoplasm
135 rdf:type schema:DefinedTerm
136 Ne58537c3f1734aed8e27e03d16f0b39a schema:familyName Poot
137 schema:givenName M
138 rdf:type schema:Person
139 Ne8768a58c87f46d3954c140631fac623 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Leukemia, Myeloid
141 rdf:type schema:DefinedTerm
142 Nf112bd6a4e7f4b13aa2c07c4a7d90a2a schema:name dimensions_id
143 schema:value pub.1022392490
144 rdf:type schema:PropertyValue
145 Nf1e30c18e508480c957428906dd8d388 rdf:first sg:person.015516000634.07
146 rdf:rest Nfdec9808a59844ac801c57be80a1a484
147 Nf6497e5c82144997bf60e57b6603fda2 rdf:first sg:person.013437631522.70
148 rdf:rest rdf:nil
149 Nf64a87553aa8440abaacd78e6f2ea6ee schema:name nlm_unique_id
150 schema:value 0370635
151 rdf:type schema:PropertyValue
152 Nfdec9808a59844ac801c57be80a1a484 rdf:first sg:person.07406565254.15
153 rdf:rest N26f326105aa144a2aa09a353491df3dd
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
158 schema:name Oncology and Carcinogenesis
159 rdf:type schema:DefinedTerm
160 sg:journal.1017082 schema:issn 0007-0920
161 1532-1827
162 schema:name British Journal of Cancer
163 rdf:type schema:Periodical
164 sg:person.01233604561.15 schema:familyName Claessen
165 schema:givenName A M
166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01233604561.15
167 rdf:type schema:Person
168 sg:person.01265440600.54 schema:familyName Oberink
169 schema:givenName J W
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265440600.54
171 rdf:type schema:Person
172 sg:person.013437631522.70 schema:familyName Pinedo
173 schema:givenName H M
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013437631522.70
175 rdf:type schema:Person
176 sg:person.015516000634.07 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
177 schema:familyName Broxterman
178 schema:givenName H J
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015516000634.07
180 rdf:type schema:Person
181 sg:person.0655351752.04 schema:familyName Lankelma
182 schema:givenName J
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655351752.04
184 rdf:type schema:Person
185 sg:person.0670102621.58 schema:familyName Eekman
186 schema:givenName C A
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670102621.58
188 rdf:type schema:Person
189 sg:person.0701655230.21 schema:familyName Hoekman
190 schema:givenName K
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701655230.21
192 rdf:type schema:Person
193 sg:person.07406565254.15 schema:familyName Schuurhuis
194 schema:givenName G J
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07406565254.15
196 rdf:type schema:Person
197 sg:pub.10.1007/bf01806527 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032011172
198 https://doi.org/10.1007/bf01806527
199 rdf:type schema:CreativeWork
200 sg:pub.10.1038/316820a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002793125
201 https://doi.org/10.1038/316820a0
202 rdf:type schema:CreativeWork
203 sg:pub.10.1038/bjc.1995.371 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020465696
204 https://doi.org/10.1038/bjc.1995.371
205 rdf:type schema:CreativeWork
206 https://app.dimensions.ai/details/publication/pub.1079935271 schema:CreativeWork
207 https://app.dimensions.ai/details/publication/pub.1082406766 schema:CreativeWork
208 https://app.dimensions.ai/details/publication/pub.1082504424 schema:CreativeWork
209 https://app.dimensions.ai/details/publication/pub.1082563921 schema:CreativeWork
210 https://app.dimensions.ai/details/publication/pub.1082650615 schema:CreativeWork
211 https://app.dimensions.ai/details/publication/pub.1082651925 schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1082889421 schema:CreativeWork
213 https://app.dimensions.ai/details/publication/pub.1082903123 schema:CreativeWork
214 https://doi.org/10.1002/ijc.2910420314 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004003162
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1002/ijc.2910610622 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025448202
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1016/0005-2736(76)90160-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003305167
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/0014-4827(89)90318-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044150193
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1016/0092-8674(91)90141-k schema:sameAs https://app.dimensions.ai/details/publication/pub.1042233556
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/0959-8049(96)00045-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012023031
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1073/pnas.87.18.7160 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053382835
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1111/j.1432-1033.1992.tb17083.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038817760
229 rdf:type schema:CreativeWork
230 https://www.grid.ac/institutes/grid.16872.3a schema:alternateName VU University Medical Center
231 schema:name Department of Medical Oncology, Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands.
232 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...